Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
13F holders, Q4 2025
Institutional positions in Kiora Pharmaceuticals Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +2 vs. Q3 2025
- Shares held
- 706.9K
- +90.8K (+14.7%) vs. Q3 2025
- Total value
- $1.39M
- −$322.0K (−18.8%) vs. Q3 2025
- New holders
- 4
- 5 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.91M |
| Q1 2026 | 18 | $654.7K |
| Q4 2025 | 19 | $1.39M |
| Q3 2025 | 17 | $1.71M |
| Q2 2025 | 16 | $2.68M |
| Q1 2025 | 18 | $3.87M |
| Q4 2024 | 16 | $4.16M |
| Q3 2024 | 19 | $5.38M |
| Q2 2024 | 17 | $5.97M |
| Q1 2024 | 24 | $7.87M |
| Q4 2023 | 15 | $159.5K |
| Q3 2023 | 14 | $91.9K |
| Q2 2023 | 18 | $425.2K |
| Q1 2023 | 14 | $283.6K |
| Q4 2022 | 11 | $518.8K |
| Q3 2022 | 9 | $209.0K |
| Q2 2022 | 14 | $391.0K |
| Q1 2022 | 16 | $517.0K |
| Q4 2021 | 13 | $1.22M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Kiora Pharmaceuticals Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 167,941 | $330.8K | 0.02% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 131,144 | $258.4K | 0.20% | −9,454−6.7% | Reduced |
| DRW Securities, LLC | 110,282 | $217.3K | 0.02% | +73,417+199.2% | Added |
| Nantahala Capital Management, LLC | 106,156 | $209.1K | 0.01% | −50,271−32.1% | Reduced |
| Alyeska Investment Group, L.P. | 76,904 | $151.5K | 0.00% | +76,904 | New |
| Vanguard Group Inc | 33,091 | $65.2K | 0.00% | +12,176+58.2% | Added |
| Citadel Advisors LLC | 22,381 | $44.1K | 0.00% | −22,192−49.8% | Reduced |
| Geode Capital Management, LLC | 22,010 | $43.4K | 0.00% | +3,157+16.7% | Added |
| Renaissance Technologies LLC | 21,200 | $41.8K | 0.00% | +8,800+71.0% | Added |
| XTX Topco Ltd | 11,971 | $23.6K | 0.00% | +11,971 | New |
| Tower Research Capital LLC (TRC) | 1,584 | $3.12K | 0.00% | +1,584 | New |
| Miller Wealth Advisors, LLC | 1,000 | $1.97K | 0.00% | +1,000 | New |
| UBS Group AG | 912 | $1.80K | 0.00% | −452−33.1% | Reduced |
| SBI Securities Co., Ltd. | 256 | $504 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 58 | $114 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 29 | $57 | 0.00% | +4+16.0% | Added |
| GWM Advisors LLC | 22 | $43 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −11,984−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,884−100.0% | Sold out |